Formulations for treatment of adipose tissue, cutaneous tissue and disorders, and muscular tissue

Details for Australian Patent Application No. 2007325523 (hide)

Owner Lithera, Inc.

Inventors Dobak, John Daniel

Agent Shelston IP

Pub. Number AU-A-2007325523

PCT Pub. Number WO2008/067060

Priority 60/852,221 17.10.06 US; 60/919,011 20.03.07 US; 60/898,009 29.01.07 US

Filing date 16 October 2007

Wipo publication date 5 June 2008

International Classifications

A61K 9/14 (2006.01) Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

A61K 31/56 (2006.01) - Compounds containing cyclopenta[a]hydrophenanthrene ring systems

A61K 31/58 (2006.01) - containing heterocyclic rings, e.g. aldosterone, danazol, stanozolol, pancuronium, digitogenin

Event Publications

28 May 2009 PCT application entered the National Phase

  PCT publication WO2008/067060 Priority application(s): WO2008/067060

2 February 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007325530-Method and apparatus for indicating uncorrectable errors to a target

2007325521-Stable suspension concentrate formulation for water-soluble compounds